Immunoprecise Antibodies Stock Market Value
| HYFT Stock | 1.73 0.08 4.85% |
| Symbol | ImmunoPrecise |
Is IT Consulting & Other Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmunoPrecise Antibodies. If investors know ImmunoPrecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmunoPrecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ImmunoPrecise Antibodies is measured differently than its book value, which is the value of ImmunoPrecise that is recorded on the company's balance sheet. Investors also form their own opinion of ImmunoPrecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is ImmunoPrecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmunoPrecise Antibodies' market value can be influenced by many factors that don't directly affect ImmunoPrecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmunoPrecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmunoPrecise Antibodies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmunoPrecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ImmunoPrecise Antibodies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ImmunoPrecise Antibodies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ImmunoPrecise Antibodies.
| 06/09/2024 |
| 12/31/2025 |
If you would invest 0.00 in ImmunoPrecise Antibodies on June 9, 2024 and sell it all today you would earn a total of 0.00 from holding ImmunoPrecise Antibodies or generate 0.0% return on investment in ImmunoPrecise Antibodies over 570 days. ImmunoPrecise Antibodies is related to or competes with CAMP4 THERAPEUTICS, ATyr Pharma,, Alx Oncology, Quince Therapeutics,, Unicycive Therapeutics, BeyondSpring, and Fractyl Health,. More
ImmunoPrecise Antibodies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ImmunoPrecise Antibodies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ImmunoPrecise Antibodies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.2 | |||
| Information Ratio | 0.0052 | |||
| Maximum Drawdown | 27.31 | |||
| Value At Risk | (7.34) | |||
| Potential Upside | 7.29 |
ImmunoPrecise Antibodies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ImmunoPrecise Antibodies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ImmunoPrecise Antibodies' standard deviation. In reality, there are many statistical measures that can use ImmunoPrecise Antibodies historical prices to predict the future ImmunoPrecise Antibodies' volatility.| Risk Adjusted Performance | 0.0217 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.37) | |||
| Sortino Ratio | 0.0052 | |||
| Treynor Ratio | 0.0368 |
ImmunoPrecise Antibodies Backtested Returns
Currently, ImmunoPrecise Antibodies is dangerous. ImmunoPrecise Antibodies holds Efficiency (Sharpe) Ratio of 0.0186, which attests that the entity had a 0.0186 % return per unit of risk over the last 3 months. We have found thirty technical indicators for ImmunoPrecise Antibodies, which you can use to evaluate the volatility of the firm. Please check out ImmunoPrecise Antibodies' Downside Deviation of 5.2, risk adjusted performance of 0.0217, and Market Risk Adjusted Performance of 0.0468 to validate if the risk estimate we provide is consistent with the expected return of 0.0977%. ImmunoPrecise Antibodies has a performance score of 1 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 2.38, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ImmunoPrecise Antibodies will likely underperform. ImmunoPrecise Antibodies right now retains a risk of 5.25%. Please check out ImmunoPrecise Antibodies semi variance, and the relationship between the treynor ratio and daily balance of power , to decide if ImmunoPrecise Antibodies will be following its current trending patterns.
Auto-correlation | -0.87 |
Excellent reverse predictability
ImmunoPrecise Antibodies has excellent reverse predictability. Overlapping area represents the amount of predictability between ImmunoPrecise Antibodies time series from 9th of June 2024 to 21st of March 2025 and 21st of March 2025 to 31st of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ImmunoPrecise Antibodies price movement. The serial correlation of -0.87 indicates that approximately 87.0% of current ImmunoPrecise Antibodies price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.87 | |
| Spearman Rank Test | -0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 0.46 |
ImmunoPrecise Antibodies lagged returns against current returns
Autocorrelation, which is ImmunoPrecise Antibodies stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ImmunoPrecise Antibodies' stock expected returns. We can calculate the autocorrelation of ImmunoPrecise Antibodies returns to help us make a trade decision. For example, suppose you find that ImmunoPrecise Antibodies has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ImmunoPrecise Antibodies regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ImmunoPrecise Antibodies stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ImmunoPrecise Antibodies stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ImmunoPrecise Antibodies stock over time.
Current vs Lagged Prices |
| Timeline |
ImmunoPrecise Antibodies Lagged Returns
When evaluating ImmunoPrecise Antibodies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ImmunoPrecise Antibodies stock have on its future price. ImmunoPrecise Antibodies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ImmunoPrecise Antibodies autocorrelation shows the relationship between ImmunoPrecise Antibodies stock current value and its past values and can show if there is a momentum factor associated with investing in ImmunoPrecise Antibodies.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ImmunoPrecise Stock Analysis
When running ImmunoPrecise Antibodies' price analysis, check to measure ImmunoPrecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunoPrecise Antibodies is operating at the current time. Most of ImmunoPrecise Antibodies' value examination focuses on studying past and present price action to predict the probability of ImmunoPrecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunoPrecise Antibodies' price. Additionally, you may evaluate how the addition of ImmunoPrecise Antibodies to your portfolios can decrease your overall portfolio volatility.